Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine, and Total Body Irradiation Conditioning Is Effective in an Elderly and Infirm PopulationJonathan E. Brammer, Richard T. Maziarz, Alexander Stentz et al.|Transplantation and Cellular Therapy|2014Cited by 11
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice GuidelinesPashna N. Munshi, Andrew Artz, Mariam Nawas et al.|Transplantation and Cellular Therapy|2025Cited by 2
Access to Allogeneic Hematopoietic Cell Transplant for Patients with Hematologic Malignancies in OregonDanielle Brouillard, Eneida R. Nemecek, Staci Williamson et al.|Transplantation and Cellular Therapy|2024Cited by 0
The Impact of Telehealth Visits on Access to Transplant Care for Recipients of Allogeneic Hematopoietic Cell Transplantation in the State of OregonArpita P Gandhi, Eneida R. Nemecek, Staci Williamson et al.|Transplantation and Cellular Therapy|2024Cited by 0
Impact of Social Determinants of Health on Access to Blood and Marrow Transplantation for Acute Myeloid LeukemiaSomya Khare, Eneida R. Nemecek, Rachel J. Cook et al.|Blood|2024Cited by 0